FOXM1 and glioblastoma: In summary, our findings provided evidence that WIN effectively inhibited human GBM cell proliferation, migration, and invasion and induces apoptosis in glioblastoma cells by triggering ROS-mediated DNA damage and regulating VEGF-AKT/FAK signals (Figure 7).